They create a vaccine against lung cancer

Cuba registered the first therapeutic vaccine against advanced lung cancer in the world, named CIMAVAX-EGF , with which more than one thousand patients have received treatment on the island, the Official Workers' Weekly reported.

The person in charge of the project of this vaccine at Center of Molecular Immunology (CIM) of Havana, Gisela González , explained that the possibility of converting the advanced cancer in a "controllable chronic disease".

The health expert said that CIMAVAX-EGF it is the result of more than 15 years of research; is directed towards the system related to the tumor and does not cause severe adverse effects:

"It's based on a protein that we all have: the epidermal growth factor, related to the processes of cell proliferation , that when there Cancer they are out of control, "said González.

This vaccine is applied at the time the patient concludes the treatment with radiotherapies or chemotherapy and is considered "terminal without therapeutic alternative," because it helps "control the growth of the tumor without associated toxicity," he said.

In addition, it can be used as a "chronic treatment that increases the patient's expectations and quality of life".

The researcher pointed out that after reaching its registration in Cuba, currently the CIMAVAX-EGF progresses in other countries and the way to use its principle in therapies against other tumors is evaluated. prostate , uterus Y moms .


Video Medicine: Is the Next Big Step in Cancer Therapy: Personalized Vaccines? (February 2023).